AnHorn Medicines
PrivateLast Round
Series A
Apr 25, 2023
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AnHorn Medicines is a clinical-stage biotechnology company developing first-in-class and best-in-class drugs for cancers, autoimmune diseases, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnHorn Medicines Comparables
Compare AnHorn Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allorion Therapeutics | 83% | |
| Black Diamond Therapeutics | 77% | |
| C4 Therapeutics | 74% |
AnHorn Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2023 |
AnHorn Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Chiao Tung University Angel Club | Series A |
| TaiAn Technologies Corp. | Series A |
| Taiwania Capital | Series A |
| Black Marble Capital Management | Series A |
| Industrial Technology Investment Corporation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 99% MoM, reaching 2.4K.
- Jul 20, 2026
Open roles increased to 17, 2.3x the trailing average.
AnHorn Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AnHorn Medicines's valuation, stock price, and market status.
Is AnHorn Medicines a public or private company?
AnHorn Medicines is a private company.
What is the current stock price of AnHorn Medicines?
AnHorn Medicines is a private company, so its shares have no public market price. Caplight tracks AnHorn Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AnHorn Medicines worth (valuation)?
Valuation information for AnHorn Medicines is not publicly available.
Can I buy AnHorn Medicines stock?
AnHorn Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AnHorn Medicines's last funding round?
AnHorn Medicines's most recent funding round was Series A on April 25, 2023.
Who are the main investors in AnHorn Medicines?
Key investors in AnHorn Medicines include Taiwania Capital.
Will AnHorn Medicines IPO soon?
No public IPO plans have been announced for AnHorn Medicines.
How can I track AnHorn Medicines secondary market activity?
Caplight tracks bids, offers, and trades in AnHorn Medicines's shares on secondary markets.